Sjogrens Syndrome Measured by Ultrasound

Disease Modification in Sjogrens Syndrome Measured by Ultrasound: A Pilot Study

Ultrasound study focused on salivary gland outcomes in Sjogren's subjects

A 32 week ultrasound study for subject diagnosed with Sjogren's Syndrome. Subjects will receive Orencia (Abatacept) as intervention therapy during this trial.

Inclusion Criteria:

• Subjects diagnosed with Sjogren's Syndrome

Exclusion Criteria:

• Subjects previously diagnosed with Sarcoidsis
• Subjects with positive for Hepatitis B, Hepatitis C, HIV
• Subjects diagnosed with Cancer within 5 years of screening